Home › B-Cell Leukemia › Colorado › Denver
B-Cell Leukemia clinical trials in Denver, CO
3 studies for B-Cell Leukemia are looking for participants at sites in and around Denver (within about 30 miles). Open a study to see who can join and how to contact the study team.
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
RecruitingPhase 2
- Colorado Blood Cancer Institute ( Site 2726), Denver
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
RecruitingPhase 3
- Research Site, Denver
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
RecruitingPhase 2
- Colorado Children's Hospital, Denver
B-Cell Leukemia trials in other cities
- Houston, TX7 studies
- Dallas, TX5 studies
- Washington, DC5 studies
- Columbus, OH4 studies
- Portland, OR4 studies
- San Diego, CA3 studies
- New York City, NY3 studies
- Clifton, NJ3 studies
- Charlotte, NC3 studies
- Philadelphia, PA3 studies
- Louisville, KY3 studies
- Boston, MA3 studies
Other studies in Denver
- Metastatic Cancer29 studies
- Breast Cancer28 studies
- Non-Small Cell Lung Cancer27 studies
- Multiple Myeloma26 studies
- Colorectal Cancer23 studies
- Cancer (all types)19 studies
- Melanoma19 studies
- Prostate Cancer19 studies
- Ovarian Cancer16 studies
- Endometrial Cancer16 studies
- Lung Cancer16 studies
- Non-Hodgkin Lymphoma14 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.